|
Market Cap (17-May) $36,803,800 (436th) |
Close (30-Jun) $0.310 |
Volume (30-Jun) 965,700 |
Shortsold (5-May) 630,735 (0.15%) (400th) |
|
52w High $0.130 |
52w Low $0.086 |
P/E 312.50 |
EPS -0.03 |
SPL released this announcement to the ASX on 9 April 2021, 13:59. The announcement is not marked as price sensitive, and is 14 page(s) in length and 300.37kb in size.
You can view all announcements from SPL and see how they appear on a price chart on the announcements page.
At the date of this announcement, SPL was 2.125% short sold according to ASIC data. It was ranked the 89th most shorted stock on the ASX. It remains ranked 400th as of the latest reported data (05 May 2025).
| Other Recent Announcements from SPL | |
|---|---|
| Clinical Trial Update | 27 June 2023, 9:57 |
| Life Sciences Investor Forum Presentation | 23 June 2023, 10:42 |
| Starpharma to present at Life Sciences Investor Forum | 22 June 2023, 12:48 |
| Appendix 2A | 9 April 2021, 13:59 |
| VIRALEZE now launched by LloydsPharmacy in the UK | 30 March 2021, 12:05 |
| VIRALEZE to be launched with LloydsPharmacy in the UK | 25 March 2021, 8:23 |
| DEP HER2-lutetium outperforms in human breast cancer model | 16 March 2021, 10:16 |
You must be logged in to post a reply.
Starpharma Holdings 